Actualización normativa

In this episode of Polyp Gossip, we explore the importance of a multidisciplinary approach in managing Chronic Rhinosinusitis with Nasal Polyps (CRSwNP). Join leading experts from rhinology and pulmonology as they discuss how collaboration across specialties can improve patient outcomes and optimize care pathways.

In this episode of Polyp Gossip, we explore the importance of a multidisciplinary approach in managing Chronic Rhinosinusitis with Nasal Polyps (CRSwNP). Join leading experts from rhinology and pulmonology as they discuss how collaboration across specialties can improve patient outcomes and optimize care pathways.

In this episode of Polyp Gossip, we explore the importance of a multidisciplinary approach in managing Chronic Rhinosinusitis with Nasal Polyps (CRSwNP). Join leading experts from rhinology and pulmonology as they discuss how collaboration across specialties can improve patient outcomes and optimize care pathways.

An infographic summarising C-peptide, a key biomarker of beta-cell function.

This page provides essential guidance for healthcare professionals on the optimal timing of influenza vaccination. It covers the seasonality of influenza, vaccine effectiveness over time, and WHO recommendations for various high-risk groups. The content aims to help healthcare providers make informed decisions about when to vaccinate their patients for maximum protection during peak influenza activity.

This page highlights the critical relationship between influenza infection and increased cardiovascular risk for healthcare professionals. It presents evidence showing how influenza can trigger heart attacks and strokes, explains the underlying mechanisms, and shares the 2023 ESC guidelines recommending influenza vaccination for all ACS patients. Essential information for clinicians managing patients with or at risk of cardiovascular disease.

Explore global real-world data from the AROMA registry on dupilumab effectiveness in CRSwNP patients, both surgery-naïve and post-surgery.

Explore global real-world data from the AROMA registry on dupilumab effectiveness in CRSwNP patients, both surgery-naïve and post-surgery.

El Profesor y Doctor Dennis A. Ostwald aborda cómo la Inteligencia Artificial (IA) y el Big Data están transformando el manejo de la diabetes en México. Se enfoca en tres áreas principales: prevención, diagnóstico y tratamiento. La IA permite una detección más temprana de la diabetes, diagnósticos más precisos y tratamientos personalizados. Aunque existen desafíos como la privacidad de datos y la regulación, el potencial de estas tecnologías para mejorar la atención médica y reducir costos es significativo. México está en una posición favorable para adoptar estas innovaciones, pero requiere un marco regulatorio adecuado y garantizar un acceso equitativo a estas herramientas tecnológicas.